The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 17, 2015
Filed:
May. 12, 2011
Applicants:
Dario Norberto R. Carrara, Oberwil, CH;
Arnaud Grenier, Steinbrunn-le-Haut, FR;
Inventors:
Dario Norberto R. Carrara, Oberwil, CH;
Arnaud Grenier, Steinbrunn-le-Haut, FR;
Assignee:
Antares Pharma IPL AG, Zug, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 13/00 (2006.01); A61K 9/70 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/025 (2006.01); A61K 31/435 (2006.01); A61K 47/08 (2006.01); A61K 47/10 (2006.01); A61K 47/12 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 9/7007 (2013.01); A61K 9/0014 (2013.01); A61K 9/006 (2013.01); A61K 9/06 (2013.01); A61K 31/025 (2013.01); A61K 31/435 (2013.01); A61K 47/08 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01); Y10S 514/946 (2013.01); Y10S 514/947 (2013.01);
Abstract
This invention relates to novel transdermal or transmucosal pharmaceutical formulation having an active agent of testosterone which reduces the occurrences of contamination of other individuals and the transference to clothing of the user. The solvent system of the formulation includes a monoalkylether of diethylene glycol and a glycol present in specified ratios, and a mixture of water and alcohol. The invention also relates to a method for inhibiting or delaying crystallization of the active agent in a pharmaceutical formulation.